glp-1 coverage news CMS Extends Medicare's Short-Term Bridge Program for Obesity Drug Poll: 1 in 8 Adults

The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.

Constipation occurs in

Learn what researchers discovered, why the findings matter, and key reminders for people with type 2 diabetes concerned about brain health.

Introduced in the twenty-first century, glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of antidiabetic drugs noted not only for their potent glucose-lowering effects but also for their cardiovascular and renal protective benefits

Sources for Figure 218

While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing